Literature DB >> 15753636

Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit.

Gul Gursel1.   

Abstract

BACKGROUND: About 10% of the patients with chronic obstructive pulmonary disease (COPD) are at high risk for prolonged mechanical ventilation (MV >21 days), and mortality ranges from 55 to 78% in these patients.
OBJECTIVE: To determine the potential risk factors for MV over periods of 1, 2 and 3 weeks in patients with COPD. PATIENTS AND
METHOD: The characteristics of patients during the stable period of their disease, on admission to the intensive care unit (ICU) and during the ICU stay were recorded prospectively and analyzed retrospectively for this study. t test, chi(2) test and logistic regression analysis were used for statistical analysis.
RESULTS: 86 patients with COPD requiring MV were included in the study. 73, 33, and 13% of the patients required MV longer than 1, 2 and 3 weeks, respectively. There were no significant relationships between the duration of MV and bronchiectasis or the presence of community-acquired pneumonia on admission, baseline pulmonary function test results or blood gas parameters on admission. Development of ventilator-associated pneumonia (VAP; odds ratio, OR: 6; 95% confidence interval, CI: 2-23, p = 0.011) and sepsis (OR: 10; 95% CI: 2-54, p = 0.007) were independent predictors for MV >7 days. VAP was still a risk factor for MV >15 days with an OR of 14 (95% CI: 3-66, p = 0.001). On the other hand MV >21 days was primarily determined by increasing age (OR: 1.2; 95% CI: 1-1.3, p = 0.042), severity of the disease on admission measured by APACHE II score (OR: 1.4; 95% CI: 1-1.7, p = 0.002) and albumin levels (OR: 0.10, 95% CI: 0.01-0.54, p = 0.007).
CONCLUSION: Advanced age, severity of disease on admission and development of VAP during ICU stay are the main determinants of MV duration in patients with COPD. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15753636     DOI: 10.1159/000083402

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

Review 1.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

2.  A rapid shallow breathing index threshold of 85 best predicts extubation success in chronic obstructive pulmonary disease patients with hypercapnic respiratory failure.

Authors:  Reza Goharani; Amir Vahedian-Azimi; Iman H Galal; Leonardo Cordeiro de Souza; Behrooz Farzanegan; Farshid R Bashar; Michele Vitacca; Seyedpouzhia Shojaei; Seyed M M Mosavinasab; Shunsuke Takaki; Andrew C Miller
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Prediction of prolonged mechanical ventilation in patients in the intensive care unit A cohort study.

Authors:  Alvaro Sanabria; Ximena Gómez; Valentín Vega; Luis Carlos Domínguez; Camilo Osorio
Journal:  Colomb Med (Cali)       Date:  2013-09-30

Review 4.  Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?

Authors:  Nicholas Heming; Saïk Urien; Christophe Faisy
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

5.  Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients.

Authors:  Nicholas Heming; Christophe Faisy; Saïk Urien
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

6.  A theoretical decision model to help inform advance directive discussions for patients with COPD.

Authors:  Negin Hajizadeh; Kristina Crothers; R Scott Braithwaite
Journal:  BMC Med Inform Decis Mak       Date:  2010-12-20       Impact factor: 2.796

7.  Factors associated with noninvasive ventilation response in the first day of therapy in patients with hypercapnic respiratory failure.

Authors:  Gul Gursel; Muge Aydogdu; Secil Tasyurek; Gazi Gulbas; Sevket Ozkaya; Sakine Nazik; Ayse Demir
Journal:  Ann Thorac Med       Date:  2012-04       Impact factor: 2.219

8.  What is new in critical illness and injury science? Acetazolamide in decompensated respiratory failure!

Authors:  Jacopo Colombo
Journal:  Int J Crit Illn Inj Sci       Date:  2015 Jan-Mar

9.  Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation.

Authors:  Mabrouk Bahloul; Anis Chaari; Ahmed Tounsi; Olfa Turki; Kamilia Chtara; Chokri Ben Hamida; Hatem Ghadhoune; Hassen Dammak; Hedi Chelly; Mounir Bouaziz
Journal:  Int J Crit Illn Inj Sci       Date:  2015 Jan-Mar

10.  Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients.

Authors:  Nicholas Heming; Saïk Urien; Virginie Fulda; Ferhat Meziani; Arnaud Gacouin; Marc Clavel; Benjamin Planquette; Christophe Faisy
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.